This year’s advisory board for CPhI Worldwide has been announced by organiser, UBM EMEA. Featuring five new global experts, the board will help shape the agenda of the CPhI Worldwide event — taking place in Frankfurt, Germany in October.
Global board
The five new members include Jim Miller, president of PharmSource, Rita Peters, editorial director of Pharmaceutical Technology, Pharmaceutical Technology Europe and BioPharm International, Peter Schmitt, president of Montesino, Claudia Lin, general manager at AlphaMab, and Kate Kuhrt, head of GTM Life Sciences, Clarivate Analytics.
In addition to shaping the meeting agenda, the board will help navigate improvements to the event’s co-located zones and sessions, as well as identifying future opportunities and current hot topics.
“CPhI Worldwide has firmly asserted itself as the leading global platform for doing business and finding new opportunities in the worldwide pharmaceutical community. We are really delighted to be able to call upon such a unique mix of industry experts to provide such invaluable insights into hot topics within the industry, alongside an abundance of knowledge and experience,” said Orhan Caglayan, brand director at UBM EMEA. “We now look to further enhance the new opportunities and services we bring to our customers.”